Divalproex Sodium Tablet, Film Coated, Extended Release
Product Images NDC 31722-022

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 31722-022). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Camberlogo (Camberlogo)

FDA Label Image

Divalproex-sodium-er-tablets-containerlabel250mg100 (Divalproex Sodium Er Tablets Containerlabel250mg100s)

Label for Divalproex Sodium Extended-Release Tablets, USP 250 mg by Camber Pharmaceuticals, Inc. The film-coated tablet is intended for once-daily dosing, with each tablet containing divalproex sodium equivalent to 250 mg valproic acid. The label displays dosing instructions, storage conditions, a barcode, and manufacturer contact information, indicating a bottle size of 100 tablets.*

FDA Label Image

Divalproex-sodium-er-tablets-containerlabel250mg500s (Divalproex Sodium Er Tablets Containerlabel250mg500s)

Label for Divalproex Sodium Extended-Release Tablets, USP 250 mg by Camber Pharmaceuticals, Inc. This label highlights once-daily dosing for oral use and specifies a bottle containing 500 extended-release film-coated tablets. It includes storage instructions, a U.S. contact number, and manufacturer details for Camber Pharmaceuticals in Piscataway, NJ.*

FDA Label Image

Divalproex-sodium-er-tablets-containerlabel500mg100s (Divalproex Sodium Er Tablets Containerlabel500mg100s)

Label for Divalproex Sodium Extended-Release Tablets, USP 500 mg by Camber Pharmaceuticals, Inc. The label indicates 100 tablets in the package with oral, once-daily dosing instructions. It includes storage directions, a U.S. contact number, and a website for the medication guide. Manufactured for Camber Pharmaceuticals in Piscataway, NJ.*

FDA Label Image

Divalproex-sodium-er-tablets-containerlabel500mg500s (Divalproex Sodium Er Tablets Containerlabel500mg500s)

Label for Divalproex Sodium Extended-Release Tablets, USP 500 mg by Camber Pharmaceuticals, Inc. The film-coated oral tablets come in a bottle containing 500 tablets. The label includes storage instructions, contact information, and barcode. Manufactured by Annora Pharma Pvt. Ltd., India.*

FDA Label Image

Figure-1 (Figure 1)

This chart compares the percentage reduction in CPS (Complex Partial Seizure) rate between patients treated with Divalproex Sodium Extended-Release Tablets and those given a placebo. The x-axis represents the percentage of patients, while the y-axis shows the reduction in CPS rate, with improvement and worsening indicated on the vertical axis. The solid line depicts the treatment effect of Divalproex Sodium and the dashed line represents placebo.*

FDA Label Image

Figure-2 (Figure 2)

A line graph showing percentage reduction in CPS rate on the y-axis against percentage of patients on the x-axis. It compares high dose and low dose Divalproex Sodium delayed-release tablets, indicating improvements and worsening in CPS rates for patients.*

FDA Label Image

Figure-3 (Figure 3)

A bar chart comparing the effects of Divalproex Sodium Extended-Release Tablets versus placebo. The chart shows two bars with values 0.6 for placebo and 1.2 for Divalproex Sodium Extended-Release Tablets, with a statistical significance noted (p = 0.006).*

FDA Label Image

Structure (Structure)

Chemical structure of divalproex sodium, depicted as a repeated polymeric structure with carboxylate (COO-) groups and sodium ions (Na+). The structure shows carbon chains with methyl (CH3) groups and carboxyl functional groups, illustrating the extended-release formulation component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.